Coronavirus Disease 2019 in Lung Transplant Recipients

Ann Thorac Surg. 2021 May;111(5):e343-e345. doi: 10.1016/j.athoracsur.2020.11.032. Epub 2020 Dec 19.


We report risk factors, clinical manifestations, and treatment course of 2 lung transplant recipients diagnosed with coronavirus disease 2019 (COVID-19) pneumonia. Both patients underwent an initial hospitalization and discharged home, followed by readmission several days later with significant worsening of respiratory status and infectious symptoms. The first patient underwent prolonged hospitalization requiring tracheostomy and feeding tube placement. The second patient declined intubation and expired. The early documented experiences of COVID-19 pneumonia in lung transplant recipients suggest that although recovery is achievable, the high rate of comorbid conditions and immunocompromised state may place these patients at higher risk for poor outcomes.

Publication types

  • Case Reports

MeSH terms

  • COVID-19 / diagnosis
  • COVID-19 / etiology*
  • COVID-19 / therapy
  • Fatal Outcome
  • Female
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Lung Diseases / surgery*
  • Lung Diseases, Interstitial / surgery
  • Lung Transplantation*
  • Middle Aged
  • Pulmonary Emphysema / surgery
  • SARS-CoV-2
  • Treatment Outcome


  • Immunosuppressive Agents